These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2043218)

  • 21. Effects of doxazosin on coronary heart disease risk factors in the hypertensive patient.
    Pool JL
    Br J Clin Pract Suppl; 1994 May; 74():8-12. PubMed ID: 8049119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The metabolic syndrome: common etiology for distinct cardiovascular risk factors?].
    Weisser B; Locher R; Vetter W
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1339-43. PubMed ID: 8272698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostics of disorders in lipid and carbohydrate metabolism in women with hypertension in outpatient clinic].
    Poliatykina TS; Al'-sveĭrki AD; Poltyrev BS; Romanenko IA; Budnikova NV; Mishina IE; Ivanova GV
    Ter Arkh; 2004; 76(1):22-5. PubMed ID: 15108431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
    Juhan-Vague I; Alessi MC; Morange PE
    Ann Med; 2000 Dec; 32 Suppl 1():78-84. PubMed ID: 11209987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Metabolic syndrome with vascular risk and arterial hypertension].
    Wassermann AO; Grosso CP
    Medicina (B Aires); 1996; 56(2):183-94. PubMed ID: 8935572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
    Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
    Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between hypertension and subtle and overt abnormalities of carbohydrate metabolism.
    Sowers JR
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S39-47. PubMed ID: 16989076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin resistance, hypertension and atherosclerosis].
    Válek J
    Cas Lek Cesk; 1994 Aug; 133(15):451-4. PubMed ID: 8082109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity, hypertension and insulin resistance.
    Sharma AM; Chetty VT
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S3-8. PubMed ID: 15868117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypofibrinolysis and the insulin resistance syndrome.
    Vague P; Raccah D; Scelles V
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S11-5. PubMed ID: 7550531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical activity and the metabolic cardiovascular syndrome.
    Westheim A; Os I
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S49-53. PubMed ID: 1283770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia.
    Flack JM; Sowers JR
    Am J Med; 1991 Jul; 91(1A):11S-21S. PubMed ID: 1867224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal.
    Elliott TG; Viberti G
    Baillieres Clin Endocrinol Metab; 1993 Oct; 7(4):1079-103. PubMed ID: 8304914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance and risk factors for coronary heart disease.
    Laws A; Reaven GM
    Baillieres Clin Endocrinol Metab; 1993 Oct; 7(4):1063-78. PubMed ID: 8304913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension, hyperlipidemia, insulin resistance and obesity: parts of a metabolic syndrome.
    Lind L; Lithell H
    Blood Press Suppl; 1992; 4():49-54. PubMed ID: 1345335
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasminogen-activator inhibitor type 1 and coronary artery disease.
    Kohler HP; Grant PJ
    N Engl J Med; 2000 Jun; 342(24):1792-801. PubMed ID: 10853003
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypertension--interaction with other coronary heart disease risk factors.
    Hansson L
    Blood Press Suppl; 1992; 1():24-5. PubMed ID: 1343267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.